Abstract | BACKGROUND: METHODS: RESULTS: KMgCit significantly increased the serum potassium concentration from 3.42 +/- 0.30 mEq/L on HCTZ alone to about 3.8 mEq/L (P < 0.001). Potassium chloride produced a similar increase in serum potassium concentration from 3.45 +/- 0.44 mEq/L to about 3.8 mEq/L (P < 0. 001). KMgCit significantly increased the serum magnesium concentration by 0.11 to 0.12 mEq/L (P < 0.01), whereas potassium chloride produced a marginal decline or no significant change. KMgCit was less effective than potassium chloride in correcting HCTZ-induced hypochloridemia and hyperbicarbonatemia. KMgCit, but not potassium chloride, significantly increased urinary pH (by about 0.6 unit), citrate (by about 260 mg/day), and urinary magnesium. CONCLUSIONS:
|
Authors | L A Wuermser, C Reilly, J R Poindexter, K Sakhaee, C Y Pak |
Journal | Kidney international
(Kidney Int)
Vol. 57
Issue 2
Pg. 607-12
(Feb 2000)
ISSN: 0085-2538 [Print] United States |
PMID | 10652038
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Citrates
- Diuretics
- Drug Combinations
- Magnesium Compounds
- Potassium Compounds
- Sodium Chloride Symporter Inhibitors
- Hydrochlorothiazide
- Potassium Chloride
- Magnesium
- potassium-magnesium citrate
|
Topics |
- Adult
- Citrates
(administration & dosage, adverse effects, urine)
- Diuretics
- Double-Blind Method
- Drug Combinations
- Female
- Humans
- Hydrochlorothiazide
(adverse effects)
- Hydrogen-Ion Concentration
- Hypokalemia
(chemically induced, drug therapy, urine)
- Kidney Calculi
(chemically induced)
- Magnesium
(blood)
- Magnesium Compounds
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Potassium Chloride
(administration & dosage, adverse effects)
- Potassium Compounds
(administration & dosage, adverse effects)
- Sodium Chloride Symporter Inhibitors
(adverse effects)
|